Caribou Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-32.0M | $-32.9M | $884.0K | $1.2M |
| FY2020 | $-33.2M | $-33.5M | $317.0K | $1.0M |
| FY2021 | $-32.5M | $-34.6M | $2.1M | $3.4M |
| FY2022 | $-91.0M | $-97.4M | $6.5M | $11.7M |
| FY2023 | $-93.3M | $-104.9M | $11.6M | $13.8M |
| FY2024 | $-138.2M | $-143.1M | $4.9M | $16.7M |
| FY2025 | $-111.0M | $-112.4M | $1.4M | $12.7M |